Schizophrenia trials in United States

In United States 179 Also abroad 473

179 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
A Virtual Reality Mindfulness Application for Aggression in Schizophrenia
Where
New York, White Plains
Age
18 years to 64 years
People
58
Run by
Manhattan Psychiatric Center
See details and how to joinNCT07434479
No phaseTaking people
Deep Brain Stimulation for Psychosis
Where
Dallas
Age
22 years to 70 years
People
10
Run by
Bradley Lega
See details and how to joinNCT06257056
No phaseTaking people
Restoring Spindle and Thalamocortical Efficiency in Early-Course Schizophrenia Patients Using Auditory Stimulation
Where
Pittsburgh
Age
18 years to 40 years
People
200
Run by
Fabio Ferrarelli
See details and how to joinNCT05956951
Phase 4Taking people
Anti-Inflammatory Challenge in Schizophrenia
Where
Atlanta
Age
18 years to 55 years
People
60
Run by
Emory University
See details and how to joinNCT05823532
Phase 4Taking people
Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
Where
Syracuse
Age
16 years to 70 years
People
2,500 worldwide
Run by
Parnassia Groep
See details and how to joinNCT05656469 · EU 2023-509680-25-00
No phaseTaking people
Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
Where
Nashville
Age
18 years to 65 years
People
100
Run by
Vanderbilt University Medical Center
See details and how to joinNCT07196462
Phase 4Not yet taking people in United States
Clinical Trial of an IL-23 Inhibitor for Immune Activation in Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With Schizophrenia
Where
Catonsville
Age
18 years to 64 years
People
40
Run by
University of Maryland, Baltimore
See details and how to joinNCT07615075
Phase 4Taking people
Cerebellum-based Imaging Neural Markers for Antipsychotic Response
Where
Glen Oaks
Age
15 years to 40 years
People
120
Run by
Northwell Health
See details and how to joinNCT07483294
Phase 4Taking people
Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
Where
Worcester
Age
18 years to 65 years
People
50
Run by
University of Massachusetts, Worcester
See details and how to joinNCT06174116
No phaseNot yet taking people in United States
NST-SPARK Open-Label Phase 1 STTR (IGNITE)
Where
Glen Oaks, Philadelphia
Age
18 years to 65 years
People
30
Run by
North Shore Therapeutics, Inc.
See details and how to joinNCT07593456
Phase 4Taking people
CLOZAPINE Response in Biotype-1
Where
Athens, Boston, Chicago, Dallas, Hartford
Age
18 years to 60 years
People
524
Run by
University of Texas Southwestern Medical Center
See details and how to joinNCT04580134
No phaseTaking people
Digital Strategies to Advance Help-Seeking Aim 1 and 2
Where
New York
Age
12 years to 29 years
People
25,000
Run by
Columbia University
See details and how to joinNCT06774430
Phase 4Taking people
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
Where
Augusta, Baltimore, Chapel Hill, Los Angeles, New York
Age
18 years to 65 years
People
280
Run by
New York State Psychiatric Institute
See details and how to joinNCT05208190
Phase 4Taking people
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
Where
Chapel Hill
Age
45 years to 55 years
People
103
Run by
University of North Carolina, Chapel Hill
See details and how to joinNCT05282277
No phaseTaking people
Racial Disparities in the Expression of Paranoia
Where
Bloomington
Age
18 years and over
People
480
Run by
Indiana University
See details and how to joinNCT07460453
Phase 2Taking people
Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia
Where
Los Angeles
Age
18 years to 60 years
People
40
Run by
University of California, Los Angeles
See details and how to joinNCT05778591
No phaseTaking people
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Where
New Haven
Age
18 years to 55 years
People
100
Run by
Yale University
See details and how to joinNCT01730781
No phaseTaking people
Database Registry for Neural Network Biomarkers in Psychosis
Where
Dallas
Age
18 years to 60 years
People
1,000
Run by
University of Texas Southwestern Medical Center
See details and how to joinNCT01409109
Phase 2Taking people
Synbiotic Compound to Reduce Symptoms of Schizophrenia
Where
Batlimore
Age
18 years to 65 years
People
68
Run by
Sheppard Pratt Health System
See details and how to joinNCT04226898
Phase 1/2Taking people
Ocrelizumab for Psychosis by Autoimmunity
Where
Houston
Age
18 years to 35 years
People
40
Run by
The Methodist Hospital Research Institute
See details and how to joinNCT03971487
No phaseTaking people
Effects of Brain Stimulation on Cognition, Oscillations and GABA Levels in Schizophrenia
Where
Sacramento
Age
18 years to 47 years
People
160
Run by
University of California, Davis
See details and how to joinNCT04267003
No phaseTaking people
Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders
Where
Houston
Age
18 years to 60 years
People
20
Run by
The University of Texas Health Science Center, Houston
See details and how to joinNCT07290738
No phaseNot yet taking people in United States
Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder
Where
New Orleans
Age
18 years to 65 years
People
34
Run by
Louisiana State University Health Sciences Center in New Orleans
See details and how to joinNCT07488156
No phaseTaking people
Cerebellar Stimulation and Cognitive Control
Where
Iowa City
Age
18 years to 90 years
People
200
Run by
Krystal Parker, PhD
See details and how to joinNCT03217110
Phase 1/2Taking people
Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
Where
Pittsburgh
Age
18 years to 65 years
People
160
Run by
Vishwajit Nimgaonkar, MD PhD
See details and how to joinNCT03794076